COMPOSITIONS AND METHODS FOR ANXIETY DISORDER TREATMENT
Provided herein are compositions comprising an alkaloid compound of formula (I) having the structure: (I) wherein R1 is H or CH3, and R2 is H or PO3H2; or pharmaceutically acceptable salt thereof in combination with a therapeutically effective amount of crocin. Such compositions may be useful in tre...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French |
Published |
30.06.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Provided herein are compositions comprising an alkaloid compound of formula (I) having the structure: (I) wherein R1 is H or CH3, and R2 is H or PO3H2; or pharmaceutically acceptable salt thereof in combination with a therapeutically effective amount of crocin. Such compositions may be useful in treatment of anxiety disorder. Further provided herein are methods for treatment of anxiety disorder comprising administering to a patient in need thereof a therapeutically effective amount of an alkaloid compound having the structure: (I) wherein R1 is H or CH3, and R2 is H or PO3H2; or pharmaceutically acceptable salt thereof in combination with a therapeutically effective amount of crocin. Optionally, the amounts are synergistic and together provide an enhanced therapeutic effect.
L'invention concerne des compositions comprenant un composé alcaloïde de formule (I) ayant la structure : (I) dans laquelle R1 représente H ou CH3, et R2 représente H ou PO3H2 ; ou un sel pharmaceutiquement acceptable de celui-ci en association avec une quantité thérapeutiquement efficace de crocine. De telles compositions peuvent être utiles dans le traitement du trouble de l'anxiété. L'invention concerne en outre des méthodes de traitement d'un trouble de l'anxiété consistant à administrer à un patient qui en a besoin une quantité thérapeutiquement efficace d'un composé alcaloïde ayant la structure : (I) dans laquelle R1 représente H ou CH3, et R2 représente H ou PO3H2 ; ou un sel pharmaceutiquement acceptable de celui-ci en association avec une quantité thérapeutiquement efficace de crocine. Facultativement, les quantités sont synergiques et fournissent conjointement un effet thérapeutique amélioré. |
---|---|
AbstractList | Provided herein are compositions comprising an alkaloid compound of formula (I) having the structure: (I) wherein R1 is H or CH3, and R2 is H or PO3H2; or pharmaceutically acceptable salt thereof in combination with a therapeutically effective amount of crocin. Such compositions may be useful in treatment of anxiety disorder. Further provided herein are methods for treatment of anxiety disorder comprising administering to a patient in need thereof a therapeutically effective amount of an alkaloid compound having the structure: (I) wherein R1 is H or CH3, and R2 is H or PO3H2; or pharmaceutically acceptable salt thereof in combination with a therapeutically effective amount of crocin. Optionally, the amounts are synergistic and together provide an enhanced therapeutic effect.
L'invention concerne des compositions comprenant un composé alcaloïde de formule (I) ayant la structure : (I) dans laquelle R1 représente H ou CH3, et R2 représente H ou PO3H2 ; ou un sel pharmaceutiquement acceptable de celui-ci en association avec une quantité thérapeutiquement efficace de crocine. De telles compositions peuvent être utiles dans le traitement du trouble de l'anxiété. L'invention concerne en outre des méthodes de traitement d'un trouble de l'anxiété consistant à administrer à un patient qui en a besoin une quantité thérapeutiquement efficace d'un composé alcaloïde ayant la structure : (I) dans laquelle R1 représente H ou CH3, et R2 représente H ou PO3H2 ; ou un sel pharmaceutiquement acceptable de celui-ci en association avec une quantité thérapeutiquement efficace de crocine. Facultativement, les quantités sont synergiques et fournissent conjointement un effet thérapeutique amélioré. |
Author | SAAD, FADIA PERRY, ROSE COFT, KEVIN |
Author_xml | – fullname: COFT, KEVIN – fullname: SAAD, FADIA – fullname: PERRY, ROSE |
BookMark | eNrjYmDJy89L5WQwd_b3DfAP9gzx9PcLVnD0c1HwdQ3x8HcJVnDzDwLyIzxdQyIVXDyD_YNcXIMUQoJcHUN8Xf1CeBhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJvLOjsZGBkZmBhaOhMRFKAA_LKbM |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | COMPOSITIONS DE PSIL3301-4-2 ET METHODES DE TRAITEMENT DE TROUBLES DE L'ANXIETE |
ExternalDocumentID | CA3202608A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CA3202608A13 |
IEDL.DBID | EVB |
IngestDate | Fri Aug 09 05:01:35 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CA3202608A13 |
Notes | Application Number: CA20213202608 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220630&DB=EPODOC&CC=CA&NR=3202608A1 |
ParticipantIDs | epo_espacenet_CA3202608A1 |
PublicationCentury | 2000 |
PublicationDate | 20220630 |
PublicationDateYYYYMMDD | 2022-06-30 |
PublicationDate_xml | – month: 06 year: 2022 text: 20220630 day: 30 |
PublicationDecade | 2020 |
PublicationYear | 2022 |
RelatedCompanies | PSILOBRAIN THERAPEUTICS INC |
RelatedCompanies_xml | – name: PSILOBRAIN THERAPEUTICS INC |
Score | 3.4032829 |
Snippet | Provided herein are compositions comprising an alkaloid compound of formula (I) having the structure: (I) wherein R1 is H or CH3, and R2 is H or PO3H2; or... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | COMPOSITIONS AND METHODS FOR ANXIETY DISORDER TREATMENT |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220630&DB=EPODOC&locale=&CC=CA&NR=3202608A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-L8Ig_St-KWdun2UKRLMlqhH2xV5tNI1w720g1X8d_3Urfpi77lA47k4JfLJfe7A3iwHGfeWSjLtHKWmXbhKDNTXQSeRfOMUcWY0mzkMGL-i_087U0bsNxxYeo8oZ91ckRE1BzxXtXn9frnEUvUsZWbx2yJQ6unUeoKY-sdU6pTSBli6MokFjE3OHe5Z0RjV5cJZ52-h47SAd6iHQ0G-TrUpJT1b4syOoXDBIWV1Rk0irIFx3xXeK0FR-H2vxubW-htzsHhcZjEk6Cm_RIvEiSUqR-LCUE_DvvTQKZvRAQT9OrkmKRj6aU6Uf8FkJFMuW_iCmb73c64t1-rdQnNclUWV0BUTgfFok-7qlA26k9RlmssDtAgW7Zjt6H9p5jrf-Zu4ESr7TsC7haa1ftHcYdmtsruawV9Ack2fDA |
link.rule.ids | 230,309,783,888,25576,76882 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOKbokb87IPZ2yJssxsPixldyaZsI1ANPpGOjYSXQWTGf9_rBPRF3_qRXNpLfr1ee787gDvTtmftuTR1M6OpbuW21FPZQeCZRpZSQ1IqFRs5imnwYj1NHiY1WGy5MFWe0M8qOSIiaoZ4L6vzevXziOVXsZXr-3SBQ8vHvnB9beMdG4ZKIaX5PZcPEz9hGmMu87R45Koy4bTteOgo7eEN21HFDvhrT5FSVr8tSv8I9ocorCiPoZYXTWiwbeG1JhxEm_9ubG6gtz4BmyXRMBmHFe2XeLFPIi6CxB8T9OOwPwm5eCN-OEavjo-IGHFPqET9p0D6XLBAxxVMd7udMm-3VvMM6sWyyM-ByMzo5nPH6MhcWqg_adBMYbGLBtm0bKsFrT_FXPwzdwuNQESD6SCMny_hUKnwOxruCurl-0d-jSa3TG8qZX0Bw_h_IA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMPOSITIONS+AND+METHODS+FOR+ANXIETY+DISORDER+TREATMENT&rft.inventor=COFT%2C+KEVIN&rft.inventor=SAAD%2C+FADIA&rft.inventor=PERRY%2C+ROSE&rft.date=2022-06-30&rft.externalDBID=A1&rft.externalDocID=CA3202608A1 |